Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas
- PMID: 22851115
- PMCID: PMC3770297
- DOI: 10.1001/jama.2012.8780
Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas
Abstract
Context: Patients with multiple colorectal adenomas may carry germline mutations in the APC or MUTYH genes.
Objectives: To determine the prevalence of pathogenic APC and MUTYH mutations in patients with multiple colorectal adenomas who had undergone genetic testing and to compare the prevalence and clinical characteristics of APC and MUTYH mutation carriers.
Design, setting, and participants: Cross-sectional study conducted among 8676 individuals who had undergone full gene sequencing and large rearrangement analysis of the APC gene and targeted sequence analysis for the 2 most common MUTYH mutations (Y179C and G396D) between 2004 and 2011. Individuals with either mutation underwent full MUTYH gene sequencing. APC and MUTYH mutation prevalence was evaluated by polyp burden; the clinical characteristics associated with a pathogenic mutation were evaluated using logistic regression analyses.
Main outcome measure: Prevalence of pathogenic mutations in APC and MUTYH genes.
Results: Colorectal adenomas were reported in 7225 individuals; 1457 with classic polyposis (≥100 adenomas) and 3253 with attenuated polyposis (20-99 adenomas). The prevalence of pathogenic APC and biallelic MUTYH mutations was 95 of 119 (80% [95% CI, 71%-87%]) and 2 of 119 (2% [95% CI, 0.2%-6%]), respectively, among individuals with 1000 or more adenomas, 756 of 1338 (56% [95% CI, 54%-59%]) and 94 of 1338 (7% [95% CI, 6%-8%]) among those with 100 to 999 adenomas, 326 of 3253 (10% [95% CI, 9%-11%]) and 233 of 3253 (7% [95% CI, 6%-8%]) among those with 20 to 99 adenomas, and 50 of 970 (5% [95% CI, 4%-7%]) and 37 of 970 (4% [95% CI, 3%-5%]) among those with 10 to 19 adenomas. Adenoma count was strongly associated with a pathogenic mutation in multivariable analyses.
Conclusions: Among patients with multiple colorectal adenomas, pathogenic APC and MUTYH mutation prevalence varied considerably by adenoma count, including within those with a classic polyposis phenotype. APC mutations predominated in patients with classic polyposis, whereas prevalence of APC and MUTYH mutations was similar in attenuated polyposis. These findings require external validation.
Figures
Comment in
-
APC gene testing for familial adenomatosis polyposis.JAMA. 2012 Aug 1;308(5):514-5. doi: 10.1001/jama.2012.9516. JAMA. 2012. PMID: 22851119 Free PMC article. No abstract available.
Similar articles
-
Contribution of APC and MUTYH mutations to familial adenomatous polyposis susceptibility in Hungary.Fam Cancer. 2016 Jan;15(1):85-97. doi: 10.1007/s10689-015-9845-5. Fam Cancer. 2016. PMID: 26446593 Free PMC article.
-
APC or MUTYH mutations account for the majority of clinically well-characterized families with FAP and AFAP phenotype and patients with more than 30 adenomas.Clin Genet. 2009 Sep;76(3):242-55. doi: 10.1111/j.1399-0004.2009.01241.x. Clin Genet. 2009. PMID: 19793053
-
Attenuated polyposis of the large bowel: a morphologic and molecular approach.Fam Cancer. 2017 Apr;16(2):211-220. doi: 10.1007/s10689-016-9938-9. Fam Cancer. 2017. PMID: 27783336
-
MUTYH-associated colorectal cancer and adenomatous polyposis.Surg Today. 2014 Apr;44(4):593-600. doi: 10.1007/s00595-013-0592-7. Epub 2013 Apr 19. Surg Today. 2014. PMID: 23605219 Review.
-
MutYH-associated polyposis.Ter Arkh. 2019 Mar 18;91(2):97-100. doi: 10.26442/00403660.2019.02.000124. Ter Arkh. 2019. PMID: 31094179 Review.
Cited by
-
The genetic basis of familial adenomatous polyposis and its implications for clinical practice and risk management.Appl Clin Genet. 2015 Apr 16;8:95-107. doi: 10.2147/TACG.S51484. eCollection 2015. Appl Clin Genet. 2015. PMID: 25931827 Free PMC article. Review.
-
Recommendations for Follow-Up After Colonoscopy and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer.Am J Gastroenterol. 2020 Mar;115(3):415-434. doi: 10.14309/ajg.0000000000000544. Am J Gastroenterol. 2020. PMID: 32039982 Free PMC article. No abstract available.
-
Recommendations for Follow-Up After Colonoscopy and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer.Gastroenterology. 2020 Mar;158(4):1131-1153.e5. doi: 10.1053/j.gastro.2019.10.026. Epub 2020 Feb 7. Gastroenterology. 2020. PMID: 32044092 Free PMC article. No abstract available.
-
Hereditary Colorectal Cancer: Clinical Implications of Genomic Medicine and Precision Oncology.J Anus Rectum Colon. 2025 Apr 25;9(2):167-178. doi: 10.23922/jarc.2025-001. eCollection 2025. J Anus Rectum Colon. 2025. PMID: 40302859 Free PMC article. Review.
-
Screening at the scope: enhancing the role of pathologists in diagnosing gastrointestinal polyposis syndromes.Virchows Arch. 2025 May 13. doi: 10.1007/s00428-025-04118-1. Online ahead of print. Virchows Arch. 2025. PMID: 40358740
References
-
- Fearnhead NS, Britton MP, Bodmer WF. The ABC of APC. Hum Mol Genet. 2001 Apr;10(7):721–733. - PubMed
-
- Van Duijvendijk P, Slors JF, Taat CW, et al. Quality of life after total colectomy with ileorectal anastomosis or proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis. Br J Surg. 2000;87(5):590–596. - PubMed
-
- Al-Tassan N, Chmiel NH, Maynard J, et al. Inherited variants of MYH associated with somatic G:C-->T:A mutations in colorectal tumors. Nat Genet. 2002 Feb;30(2):227–232. - PubMed
-
- Jones S, Emmerson P, Maynard J, et al. Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C-->T:A mutations. Hum Mol Genet. 2002 Nov 1;11(23):2961–2967. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials